COR vs HSIC
COR: North America's largest pharmaceutical and healthcare product distributor, serving pharmacies, hospitals, and health systems with branded and generic drugs, medical supplies, and specialty healthcare services. HSIC: A global, one-stop-shop distributor of medical and dental supplies, specialized equipment, and practice management software for office-based health care providers.
Side-by-side fundamentals
| Metric | COR | HSIC | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $311.15 | $84.61 | |
| Market cap as of 2026-07-30 | $62.0B | $9.8B | |
| P/E as of 2026-07-30 | 24.32 | 24.69 | COR lower |
| PEG as of 2026-07-30 | 2.03 | 2.66 | COR lower |
| Net margin as of 2026-07-30 | +0.8% | +3.0% | HSIC higher |
| Gross margin as of 2026-07-30 | +3.8% | +31.2% | HSIC higher |
| Operating margin as of 2026-07-30 | +0.8% | +4.9% | HSIC higher |
| ROE as of 2026-07-30 | +115.9% | +11.9% | COR higher |
| ROA as of 2026-07-30 | +3.3% | +3.5% | HSIC higher |
| Debt / equity as of 2026-07-30 | 3.65 | 1.04 | HSIC lower |
| Revenue growth (YoY) as of 2026-07-30 | +6.0% | +5.6% | COR higher |
| Revenue CAGR (3y) SEC XBRL | +10.4% | +1.4% | COR higher |
| Dividend yield as of 2026-07-30 | +0.8% | n/a | |
| Dividend streak (yrs) SEC XBRL | 4 | n/a | |
| Beta as of 2026-07-30 | 0.57 | 0.81 | |
| 1-year return as of 2026-07-27 close | +7.2% | +18.4% | HSIC higher |
Fundamentals: market data, as of 2026-07-30. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.